A股“医药一哥”,迈向盈利新纪元

生物制药小编
10 May

2025年,在持续低迷近4年之后,A股医药板块迎来了一个历史性的事件。截至2025年5月8日收盘,科创板上市的创新药企业百济神州,以超过3300亿人民币的市值,继续稳居医药板块市值第一名。在成功实现科创板IPO仅3年多的时间以后,百济神州正式加冕A股“医药一哥”的桂冠。这不仅是A股医药板块估值体系切换的标志性事件,更是整个创新药产业发展过程中的里程碑:以百济神州为代表的新一代创新药企业,凭借全球...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10